San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.
Scripps Research joins national program to solve complex biological problems.
Researchers at University of California, San Diego School of Medicine have been awarded a $9.2 million grant to help modernize and transform how researchers share, use, find and cite biomedical datasets.
Researchers from San Diego-based ViaCyte and UC San Diego provided new details about the first-ever human clinical trial of a stem cell-derived therapy for patients with type 1 diabetes yesterday at…
[[Click headline to continue reading.]]
Isis Pharmaceuticals Reports Data From ISIS-SMN Rx Phase 2 Studies in Infants and Children With Spinal Muscular Atrophy* Phase 3 ENDEAR study in infants with SMA enrolling; on track to initiate Phase 3 study in children with SMA later this year*Isis to host a webcast at 11:30 a.m. EDT on Friday, October 10